|
|||||||||||||||
|
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016 Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) |
||||||||||||||
Issue: May 2024
Volume 9 | Issue 5
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.76
Issue per Year : 12
Volume Published : 9
Issue Published : 96
Article Submitted :
Article Published :
Total Authors :
Total Reviewer :
Total Countries :
Indexing Partner
Join RMS/Earn 300
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | A CLINICAL STUDY ON WAJA-UL-MUFASIL (RHEUMATOID ARTHRITIS) AND ITS MANAGEMENT IN UNANI MEDICINE |
| Authors Name: | Dr.SHEEMA MARIYAM , Dr.N.Narasimha , Dr. Mohammed Ahsan Faroqui , Dr. Shaheen |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJNRD_214678
|
| Published Paper Id: | IJNRD2403267 |
| Published In: | Volume 9 Issue 3, March-2024 |
| DOI: | |
| Abstract: | A CLINICAL STUDY ON WAJA-UL-MUFASIL(RHEUMATOID ARTHRITIS) AND ITS MANAGEMENT IN UNANI MEDICINE *Dr..Sheema Mariyam **Dr..N.Narasimha MD (Professor) ***Dr.. Mohammed Ahsan Faroqui, HOD PG.dept. of Moalejat. Govt. Niazmia Tibbi College Charminar, Hyd. ABSTRACT: Introduction: Rheumatoid arthritis (RA) is a long-standing inflammatory condition of undetermined causative factors with the hallmark of symmetric joint involvement. It is an autoimmune disease in which the body's immune system of the patient innocently targets its own body tissues. It principally attacks the synovial membrane. The most prevalent inflammatory arthritic condition, Rheumatoid arthritis (RA) affects 0.5% to 1% of the global population. It affects 15% (180 million) of the population of India. In the classical Unani literature, waja-ul-mufasil (RA) occurs in various joints caused by derangement of the body’s natural humours i.e., dam (blood), balgham (phlegm), safra (bile), and sauda (black bile) with various explanations mentioned by great scholars in Unani literature.The onset of the disease is insidious, beginning with prodrome of fatigue, weakness, joint stiffness, vague arthralgias and myalgias followed by pain and swelling. The most common age of onset is between 30 and 50 years.The cause is multifactorial and genetic and environmental factors play a part. Female gender is more susceptible. AIMS & OBJECTIVES: To evaluate the safety and efficacy of unani drugs in cases of Waja-ul-Mufasil (Rheumatoid Arthritis) and to prevent the long term side effects of DMARD’S, NSAID’S and CORTICOSTEROIDS. Methodology: The study of Waja-ul-Mufasil (Rheumatoid Arthritis) and its management with unani medicine was carried out in OPD of Govt. Nizamia General Hospital, Charminar, Hyderabad. It is A Single blind clinical trial to evaluate the safety and efficacy of Waja-ul -Mufasil (Rheumatoid Arthritis) with polyherbal unani formulation. Sample size of RA is 40 patients of either sex 18-50 years were taken. In this study patients were given polyherbal unani formulation for the total duration of treatment of 51 days i.e., orally in the form of decoction for 21 days based on formulations of unani Drugs having properties like Mushil balgham o sauda (Purgative), Mohalil e auram (Resolvent). After the period of 21 days of decoction, patients were given unani medicine possessing the properties of Musaffi khoon (Blood purifier), Musakkin Alam (Analgesic), Muqavvi Aasab (Nervine tonic) for next 30 days. Results and Conclusion: The study revealed that the drug showed extreme statistical significance P value <0.0001 in subjective parameters like Pain, Tenderness, Swelling, Morning stiffness, and Any deformity. The objective parameters like RA factor, ESR also showed the significant difference P value <0.0001. No adverse effect or toxicity was observed during clinical trial. |
| Keywords: | Key word: Waja-ul-Mufasil (Rheumatoid Arthritis), Autoimmune disease, Unani medicines, Humours, Mushil balgham o sauda (Purgative), Mohalil e auram (Resolvent), Musaffi khoon (Blood purifier), Musakkin Alam (Analgesic), Muqavvi Aasab (Nervine tonic). |
| Cite Article: | "A CLINICAL STUDY ON WAJA-UL-MUFASIL (RHEUMATOID ARTHRITIS) AND ITS MANAGEMENT IN UNANI MEDICINE", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.9, Issue 3, page no.c504-c529, March-2024, Available :http://www.ijnrd.org/papers/IJNRD2403267.pdf |
| Downloads: | 00035 |
| ISSN: |
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID:IJNRD2403267 Registration ID: 214678 Published In: Volume 9 Issue 3, March-2024 DOI (Digital Object Identifier): Page No: c504-c529 Country: Hyderabad, Telangana, India Research Area: Medical Science Publisher : IJ Publication Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2403267 Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2403267 |
| Share Article: |
|
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijnrd.org
| Semantic Scholar | Microsaoft Academic | ORCID | Zenodo |
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | PUBLON |
| DRJI | SSRN | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Join RMS/Earn 300
| Copyright © 2024 - All Rights Reserved - IJNRD |
Facebook Twitter Instagram LinkedIn